Key Takeaways
- POET Technologies shares rocketed 108% over the week, reaching an 11-year peak of $15.50 during Friday’s session
- The explosive move followed confirmation of a supply agreement with Marvell Technology for 800G optical engines
- Chief Financial Officer Thomas Mika disclosed that orders are anticipated to drive total 2025 order volume beyond $5 million, with shipments commencing in Q3
- Shares retreated to $15.10 (+28.84%) by Friday’s close as investors locked in profits
- CNBC’s Jim Cramer warned the stock is “trading like they’re already in mass production” despite operations remaining at limited scale
POET Technologies shares peaked at $15.50 during Friday trading before settling at $15.10, marking a single-day increase of 28.84%. The week-over-week surge reached 108%, propelling the stock to levels not seen since August 2014.
The primary driver behind this rally was the announcement of a supply partnership with Marvell Technology. CFO Thomas Mika revealed via Stocktwits that POET had formally confirmed purchase orders from Marvell for its 800G optical engine products.
According to Mika, these orders are projected to elevate POET’s complete 2025 order backlog above the $5 million threshold. The company anticipates initial shipments will commence during the third quarter of 2025.
Additionally, the company awaits decisions from two other prospective customers: Foxconn and Luxshare. “We expect to hear back from at least one of those,” Mika stated.
The company’s year-to-date performance now reflects a gain of 138.55%, with market capitalization currently standing at $2.31 billion.
Intraday Reversal
The morning surge attracted momentum-focused traders, contributing to the stock reaching its session peak. However, when profit-taking activity intensified, the advance quickly reversed course.
A short squeeze dynamic added intensity to both the upward momentum and subsequent decline. Substantial trading activity — with average daily volume exceeding 13.7 million shares — magnified price movements in both directions.
Company leadership also addressed a recent short-seller critique during the week. Announcements regarding potential U.S. redomiciliation temporarily boosted investor sentiment, though this optimism dissipated absent additional developments.
Analyst price projections remained largely unchanged following Friday’s price action. Technical indicators for the stock continue to signal a buy rating.
Cramer’s Perspective
Jim Cramer, former hedge fund manager and Mad Money host, expressed skepticism regarding POET’s valuation.
“Let’s not get ahead of ourselves with these recent announcements,” Cramer commented. “POET’s got a joint development agreement. They’re not producing this stuff at scale.”
He continued: “The stock’s trading like they’re already in mass production, and that bothers me. Just look at the numbers. POET’s financials make it look more of a science project than a business.”
Cramer emphasized the significant difference between laboratory-stage technology and full-scale commercial production as the primary risk factor investors should evaluate.
POET’s current confirmed status: purchase orders from Marvell finalized, responses from Foxconn and Luxshare awaited, Q3 shipment timeline established.


